Covered recipient · General Payments record
HARRY KERASIDIS
General Payments · PY2018–2022
$40,473.17
- Reported across 281 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $133.55 | 7 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $40.40 | 2 |
| ABBVIE INC. | $34.87 | 2 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $23.02 | 1 |
| Supernus Pharmaceuticals, Inc. | $21.18 | 1 |
| Lilly USA, LLC | $14.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (7)
Sorted by paying entity, then date · as published by CMS
Program year 2022 2018201920202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.92 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893050295 | CMS |
| ABBVIE INC. | $21.95 | 03/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893050297 | CMS |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.02 | 02/02/2022 | Food and Beverage | Undisputed | 01/23/2026 | 923635735 | CMS |
| Lilly USA, LLC | $14.08 | 02/21/2022 | Food and Beverage | Undisputed | 01/23/2026 | 918032421 | CMS |
| Novartis Pharmaceuticals Corporation | $21.42 | 02/03/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893825065 | CMS |
| Novartis Pharmaceuticals Corporation | $18.98 | 02/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 893825069 | CMS |
| Supernus Pharmaceuticals, Inc. | $21.18 | 01/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 952984261 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.